DELAYED RELEASE OF PROSTAGLANDINS FROM ARACHIDONIC-ACID AND KINETIC CHANGES IN PROSTAGLANDIN-H SYNTHASE ACTIVITY ON THE INDUCTION OF PROSTAGLANDIN-H SYNTHASE-2 AFTER LIPOPOLYSACCHARIDE-TREATMENT OF RAW264.7 MACROPHAGE-LIKE CELLS
Y. Tanaka et al., DELAYED RELEASE OF PROSTAGLANDINS FROM ARACHIDONIC-ACID AND KINETIC CHANGES IN PROSTAGLANDIN-H SYNTHASE ACTIVITY ON THE INDUCTION OF PROSTAGLANDIN-H SYNTHASE-2 AFTER LIPOPOLYSACCHARIDE-TREATMENT OF RAW264.7 MACROPHAGE-LIKE CELLS, Biological & pharmaceutical bulletin, 20(4), 1997, pp. 322-326
In a mouse macrophage-like cell line, RAW264.7, arachidonic acid was c
leaved within 30 min of lipopolysaccharide (LPS)-treatment, However, p
rostaglandin (PG) synthesis did not accompany this cleavage, being del
ayed by 4h, although significant PGH synthase (PGHS) activity was dete
cted in the lysate of LPS-nontreated cells. The K-m value of this basa
l PGHS activity toward arachidonic acid was more than one hundred-fold
higher than that for the lysate of cells treated with LPS for 4h. Cha
nges in the sensitivity of the PGHS activity to nonsteroidal antiinfla
mmatory drugs after LPS-treatment also suggested induction of PGHS wit
h different properties from that in the case of basal PGHS. The concom
itant increase in PGH synthase (PGI-IS) activity with the induction of
PGHS-2 protein after LPS-treatment suggested a contribution by PGHS-2
to the delayed synthesis of PGs in LPS-treated macrophage cells. As f
or PGHS in the control cells without LPS-treatment, a different K-m va
lue from that of PGHS-1 and the lack of cross-reactivity to anti-PGHS-
1 antibodies suggested that this basal PGHS was different from the typ
ical PGHS-1. The lower affinity of this enzyme for arachidonic acid mi
ght be the reason for the failure to release PGs by the cells without
LPS-treatment.